-
Amgen's DMab scores in trials
For the biotech, a new drug for bone cancer and osteoporosis could mean a big boost in revenue.By Alyssa AbkowitzAn Amgen trial drug -- called denosum...
-
安進(jìn)新藥DMab在試驗(yàn)中獲得成功
對(duì)于安進(jìn)這家生物技術(shù)公司而言，一種治療骨癌和骨質(zhì)疏松癥的新藥可能使其收入大大增加。作者：Alyssa Abkowitz安進(jìn)（Amgen）的一種試用藥物——名為狄諾塞麥(denosumab)——于7月7日達(dá)到新的里程碑，這家生物技術(shù)公司宣布了該藥物針對(duì)骨癌的最新臨床試驗(yàn)結(jié)果。對(duì)2000多名患者的試驗(yàn)顯...
-
Eli Lilly's patent problem
In 2009, Eli Lilly CEO John Lechleiter introduced a new drug development strategy called the Development Center of Excellence. The center's mission is...
-
Cisco's 'earth-shattering' announcement
For all you folks who had dreams of flying cars or Cisco (CSCO) announcing the purchase of EMC, what CEO John Chambers revealed Tuesday after weeks of...
-
Tim Geithner's latest headache
The treasury secretary's bid to rein in derivatives meets skepticism.By Carol J. LoomisThe Obama Administration has given itself two months to tell Co...
-
It's a phone! It's a browser! It's a wallet?
By Jessica ShamboraWill your cellphone soon become a proxy for your credit card? Zong and others are betting on it.If there’s one thing online merchan...
-
What's so great about working at Goldman?
The past 12 months have undoubtedly had Goldman Sachs (GS, Fortune 500) wishing for an invisibility cloak. The bank was sued by the SEC for trading ac...
-
Amazon's newest Kindle takes aim at newspapers
Amazon hopes to convert readers of magazines and newspapers to its newest e-book reader, the Kindle DX.By Jessica ShamboraThe question of whether Amaz...
-
科技業(yè)下一波浪潮：當(dāng)大數(shù)據(jù)遇上生物學(xué)
去年12月，CVS提出以690億美元收購(gòu)安進(jìn)保險(xiǎn)公司。今年1月，又有三大巨頭——亞馬遜、摩根大通和伯克謝爾哈撒韋表示要成立合資公司，降低共100萬(wàn)左右員工的醫(yī)療成本并提高效果。之后3月，信諾保險(xiǎn)表示將出資超過(guò)500億美元收購(gòu)醫(yī)藥福利管理機(jī)構(gòu)Express Scripts。為何近來(lái)醫(yī)療領(lǐng)域交易如此熱鬧...
-
制藥巨頭抱團(tuán)能圓發(fā)財(cái)夢(mèng)嗎？
三年前，美國(guó)衛(wèi)生部門官員曾建議大型制藥公司共同開(kāi)發(fā)治療藥物而不是相互競(jìng)爭(zhēng)，當(dāng)時(shí)這些公司的反應(yīng)很矛盾。畢竟，大型制藥公司是競(jìng)爭(zhēng)最激烈而且自我保護(hù)力度極大的領(lǐng)域之一。這些企業(yè)為本公司藥品的方方面面都申請(qǐng)了專利；對(duì)于侵害自己利益的對(duì)手，它們會(huì)予以回?fù)?；專利到期后，為了阻擋?jìng)爭(zhēng)者，它們會(huì)發(fā)起價(jià)格戰(zhàn)。但現(xiàn)在，...
時(shí)間：
作者：
關(guān)鍵詞：
